Related by context. Frequent words. (Click for all words.) 64 Hsp# inhibitors 63 investigational compounds 61 Voreloxin 61 Azedra 61 xenograft models 61 BAY #-# 60 EpCAM 60 orally bioavailable 60 anticancer therapy 59 HER2 positive metastatic breast 59 hematologic malignancies 59 angiogenesis inhibitor 59 NNRTIs 58 axitinib 58 #ME# 58 temsirolimus 58 SCH # 58 immunomodulator 58 PARP inhibitors 58 tyrosine kinase inhibitor 58 Serdaxin 58 potent inhibitor 58 Atiprimod 58 glioblastoma multiforme GBM 58 HGS ETR1 58 Nimotuzumab 58 RGB # 57 immunomodulatory 57 Note Babble 57 GRN#L 57 humanized monoclonal antibody 57 decitabine 57 CYC# 57 malignant pleural mesothelioma 57 anticancer agents 57 Perifosine 57 CA4P 57 talabostat 57 antitumor activity 57 MAb 57 hematological cancers 57 6R BH4 57 selective inhibitor 57 IMC A# 56 tanespimycin 56 EGFR inhibitors 56 hematological malignancies 56 tyrosine kinase inhibitors 56 solid tumors 56 preclinical models 56 metastatic renal cell carcinoma 56 lupus nephritis 56 CR# vcMMAE 56 relapsed refractory multiple myeloma 56 zileuton 56 DAVANAT 56 gastrointestinal stromal tumors 56 hematologic cancers 56 chemotherapeutic agent 55 PEG Interferon lambda 55 seliciclib 55 CYT# 55 AZX# 55 androgen independent 55 IGF 1R 55 pharmacokinetic profiles 55 potent antiviral 55 vandetanib 55 cytotoxicity 55 imatinib mesylate 55 Neuradiab 55 chronic HCV infection 55 clinically validated 55 humanized anti 55 multiple sclerosis rheumatoid arthritis 55 TORISEL 55 OXi# 54 chemotherapeutic agents 54 hypoxia inducible factor 54 cutaneous T cell 54 PXD# 54 systemic lupus erythematosus SLE 54 dose cohorts 54 therapeutic monoclonal antibodies 54 KNS # 54 interferon alpha 54 vicriviroc 54 sunitinib 54 SUTENT 54 Maraviroc 54 HDAC inhibitors 54 belinostat 54 Preclinical studies 54 diabetic nephropathy 54 Phase IIa trial 54 resistant ovarian cancer 54 GSK # 54 tezampanel 53 B CLL 53 sirolimus 53 fibrotic diseases